Th2 immune pathway

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas
Yahoo/Wall St 24-7
Mon, 09/16/13 - 10:09 am
biotech
Th2 immune pathway
MS
multiple sclerosis
Biogen Idec
Regeneron
Sanofi
GSK